NRx Pharmaceuticals, Inc. (NRXP) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 5 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for NRXP is $2.00, representing a -20.6% downside from the current price of $2.52. Price targets range from a low of $2.00 to a high of $2.00.
